Altogether, these findings suggest a possible role of GLP‐1 RAs in modulating HF outcomes perhaps through mechanisms not entirely dependent on body weight reduction, such as improvements in endothelial function, reductions in oxidative stress and inflammation, myocardial substrate utilization, and modulation of natriuresis, that contribute to CV and renal protection. Here, GLP1R is linked to hydrops fetalis.